Main Article Content
Erectile dysfunction; diabetes; sexual dysfunction; glycemic control; Saudi Arabia.
Background and objective
This study aimed to determine the validity of using a single-question self-report of erectile dysfunction (ED) as a screening tool among Saudi men with type 2 diabetes mellitus (T2DM).
Materials and methods
A cross-sectional study was conducted using a single-question self-report questionnaire to determine the association between the risk of ED and poor glycemic control among men with T2DM. The study was conducted in a hospital-based diabetes clinic in Riyadh, Saudi Arabia. Married adults (aged >18 years) suffering from T2DM for at least 1 year were included in the study. All statistical analy-ses were performed using SAS version 9.2 and R software (Foundation for Statistical Computing, Vienna, Austria).
With 86% response rate, 293 participants were included in this study. Over half (53.9%) of the partic-ipants were below 60 years of age. More than half (55.3%) were suffering from uncontrolled diabetes (i.e., HbA1c > 7%). There was significant correlation between the International Index of Erectile Function (IIEF) and self-reported question in terms of duration of T2DM (p < 0.001), type of treatment (p = 0.004), income of the participants (p = 0.005), age (p < 0.001), education level (p = 0.032), and occupation (p < 0.001). However, there was no significant correlation between IIEF and self-reported question in terms of body mass index (p = 743) and smoking. Regarding overall diagnostic accuracy of IIEF score to predict self-reported ED, receiver operating characteristic curve showed area under curve as 89.4%, which is sta-tistically significant.
Single-question self-report of ED is a valid and reliable tool to screen diabetic patients suffering from sexual problems. Such tool may help to identify ED in diabetic patients and warrant early management.
2. Oyelade BO, Jemilohun AC, Aderibigbe SA. Prevalence of erectile dysfunction and possible risk factors among men of south-western Nigeria: A population-based study. Pan Afr Med J 2016;24(1).
3. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study. J Urol 2000;163(2):460–3. https://doi.org/10.1016/ S0022-5347(05)67900-1
4. Liu Q, Zhang Y, Wang J, Li S, Cheng Y, Guo J, et al. Erectile dysfunction and depression: A systematic review and meta-analysis. J Sex Med 2018; 15(8):1073–82. https://doi.org/10.1016/j.jsxm.2018. 05.016
5. Goldstein I, Goren A, Li V, Tang WY, Hassan TA. Erectile dysfunction prevalence, patient characteristics, and health outcomes globally. J Sex Med 2017;14(5):e298. https://doi.org/10.1016/j.jsxm.2017. 04.433
6. Gerbild H, Larsen CM, Graugaard C, Josefsson KA. Physical activity to improve erectile function: A systematic review of intervention studies. J Sex Med 2018;6(2):75–89. https://doi.org/10.1016/j. esxm.2018.02.001
7. McKinlay J. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000;12(S4):S6. https://doi.org/10.1038/sj.ijir. 3900567
8. DeLay KJ, Haney N, Hellstrom WJ. Modifying risk factors in the management of erectile dysfunction: A review. World J Men Health 2016;34(2):89–100. https://doi.org/10.5534/wjmh.2016.34.2.89
9. Köseoğlu N, Köseoğlu H, Ceylan E, Cimrin HA, Ozalevli S, Esen A. Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive pulmonary disease. J Urol 2005;174(1):249– 52. https://doi.org/10.1097/01.ju.0000163259.33846.74
10. Shiri R, Häkkinen JT, Hakama M, Huhtala H, Auvinen A, Tammela TL, et al. Effect of lower uri-nary tract symptoms on the incidence of erectile dysfunction. J Urol 2005;174(1):205–9. https://doi. org/10.1097/01.ju.0000162042.90554.64
11. Binmoammar TA, Hassounah S, Alsaad S, Rawaf S, Majeed A. The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: A systematic review. JRSM Open 2016;7(3):2054270415622602. https:// doi.org/10.1177/2054270415622602
12. Chao JK, Ma MC, Chao HC. Erectile dysfunction, hormone levels, inflammation in male patients with metabolic syndrome. J Men Health 2018;14(4): e25–37. https://doi.org/10.22374/1875-68188.8.131.52
13. Kratzik CW, Schatzl G, Lunglmayr G, Rücklinger E, Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 2005;174(1): 240–3. https://doi.org/10.1097/01.ju.0000162049. 95483.51
14. Gökçe Mİ, Yaman Ö. Erectile dysfunction in the elderly male. Turk J Urol 2017;43(3):247. https://doi. org/10.5152/tud.2017.70482
15. Sanchez E, Pastuszak AW, Khera M. Erectile dys-function, metabolic syndrome, and cardiovascular risks: Facts and controversies. Transl Androl Urol 2017;6(1):28. https://doi.org/10.21037/tau.2016.10.01
16. Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of erectile dysfunction in diabetes: A systematic review and meta-analysis of 145 studies. Diab Med 2017;34(9):1185–92. https://doi.org/10.1111/ dme.13403
17. AlMogbel TA. Erectile dysfunction and other sex-ual activity dysfunctions among Saudi type 2 diabetic patients. Int J Health Sci 2014;8(4):347. https:// doi.org/10.12816/0023992
18. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009;6(5):1232–47. https://doi.org/10.1111/j.1743-6109.2008.01168.x
19. Seid A, Gerensea H, Tarko S, Zenebe Y, Mezemir R. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospi-tals of central and northwestern zone of Tigray, northern Ethiopia: A cross-sectional study. BMC Endoc Disord 2017;17(1):16. https://doi.org/10.1186/ s12902-017-0167-5
20. McGuire H, Longson D, Adler A, Farmer A, Lewin I, Guideline Development Group. Management of type 2 diabetes in adults: Summary of updated NICE guidance. BMJ 2016;353:i1575. https://doi. org/10.1136/bmj.i1575
21. Pastuszak AW. Current diagnosis and management of erectile dysfunction. Curr Sex Health Rep 2014;6(3):164–76. https://doi.org/10.1007/s11930-014-0023-9
22. Chung CM, Lu MZ, Wong CY, Goh SG, Azhar MI, Lim YM, et al. The SAD–MEN questionnaire: A new and reliable questionnaire for assessing sex-ual dysfunction in Asians with diabetes. Diab Med 2016;33(5):674–80. https://doi.org/10.1111/ dme.12864
23. O’Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ. A brief male sexual function inventory for urology. Urology 1995;46(5):697–706. https://doi.org/10.1016/ S0090-4295(99)80304-5
24. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49(6):822–30. https://doi.org/10.1016/ S0090-4295(97)00238-0
25. Kleinman KP, Feldman HA, Johannes CB, Derby CA, McKinlay JB. A new surrogate variable for erectile dysfunction status in the Massachusetts Male Aging Study. J Clin Epidemiol 2000;53(1):71– 8. https://doi.org/10.1016/S0895-4356(99)00150-X
26. Çayan S, Kendirci M, Yaman Ö, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group. Turk J Urol 2017;43(2):122. https://doi.org/10.5152/tud.2017.24886
27. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression: Two questions are as good as many. J Gen Intern Med 1997;12(7):439–45. https://doi. org/10.1046/j.1525-1497.1997.00076.x
28. Peralta RL, Fleming MF. Screening for intimate partner violence in a primary care setting: The validity of “feeling safe at home” and prevalence results. J Am Board Fam Pract 2003;16(6):525–32. https://doi.org/10.3122/jabfm.16.6.525
29. Eardley I. The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 2013;1(1):3–16. https://doi.org/10.1002/smrj.2
30. O’donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction: Results from the Massachusetts Male Aging Study. J Gen Intern Med 2005;20(6):515– 19. https://doi.org/10.1111/j.1525-1497.2005.0076.x
31. Lo WH, Fu SN, Wong CKH, San Chen E. Prevalence, correlates, attitude and treatment seek-ing of erectile dysfunction among type 2 diabetic Chinese men attending primary care outpatient clinics. Asian J Androl 2014;16(5):755. https://doi. org/10.4103/1008-682X.127823
32. Almigbal TH. Erectile dysfunction in men with type 2 diabetes: Is it associated with poor glycemic control? J Mens Health 2019;15(1):e12–22. https:// doi.org/10.22374/jomh.v15i1.104
33. Alwin Robert A, Abdulaziz Al Dawish M, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH. Type 2 diabetes mellitus in Saudi Arabia: Major challenges and possible solutions. Curr Diab Rev 2017;13(1):59–64. https://doi.org/10 .2174/1573399812666160126142605
34. Aldossari KK, Aldiab A, Al-Zahrani JM, Al-Ghamdi SH, Abdelrazik M, Batais MA, et al. Prevalence of prediabetes, diabetes, and its associated risk factors among males in Saudi Arabia: A popu-lation-based survey. J Diab Res 2018;2018:2194604. https://doi.org/10.1155/2018/2194604
35. Al-Zahrani JM, Aldiab A, Aldossari KK, Al-Ghamdi S, Batais MA, Javad S, et al. Prevalence of prediabetes, diabetes and its predictors among females in Alkharj, Saudi Arabia: A cross-sectional study. Ann Glob Health 2019;85(1):109. https://doi. org/10.5334/aogh.2467
36. Meo SA. Prevalence and future prediction of type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A systematic review of published studies. JPMA J Pak Med Assoc 2016;66(6):722–5.
37. Alramadan MJ, Magliano DJ, Almigbal TH, Batais MA, Afroz A, Alramadhan HJ, et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia – An urgent need for a review of management plan. BMC Endocr Disord 2018;18(1):62. https://doi.org/10.1186/s12902-018-0292-9
38. Almigbal TH, Schattner P. The willingness of Saudi men with type 2 diabetes to discuss erectile dysfunction with their physicians and the factors that influence this. PLoS One 2018;13(7):e0201105. https://doi.org/10.1371/journal.pone.0201105
39. Utomo E, Blok B, Pastoor H, Bangma CH, Korfage IJ. The measurement properties of the five-item International Index of Erectile Function (IIEF-5): A Dutch validation study. Andrology 2015;3(6): 1154–9. https://doi.org/10.1111/andr.12112
40. Derby CA, Araujo A, Johannes C, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: The use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impotence Res 2000;12(4):197. https://doi.org/10.1038/sj.ijir.3900542
41. Goyal A, Singh P, Ahuja A. Prevalence and severity of erectile dysfunction as assessed by IIEF-5 in North Indian type 2 diabetic males and its correlation with variables. J Clin Diagn Res JCDR 2013;7(12):2936. https://doi.org/10.7860/JCDR/2013/7718.3777
42. Park J, Kwon J, Cho SY, Cho MC, Paick JS, Kim SW. Comparison of improving effects for diabetic erectile dysfunction according to the anti-glycemic agents: Phlorizin and insulin. World J Mens Health 2019 May;37(2):210–18. https://doi.org/10.5534/ wjmh.180057
43. Song WH, Park J, Yoo S, Oh S, Cho SY, Cho MC, et al. Changes in the prevalence and risk factors of erectile dysfunction during a decade: The Korean Internet Sexuality Survey (KISS), a 10-year-in-terval web-based survey. World J Mens Health 2019 May;37(2):199–209. https://doi.org/10.5534/ wjmh.180054
44. Prabhakaran DK, Nisha A, Varghese PJ. Prevalence and correlates of sexual dysfunction in male patients with alcohol dependence syndrome: A cross-sectional study. Indian J Psychiatry 2018;60(1):71. https://doi. org/10.4103/psychiatry.IndianJPsychiatry_42_17